Business
First Participant Dosed in Phase I Study of IMP761
First Participant Dosed in Phase I Study of IMP761

About this update from Immutep Ltd
[{"type":"text","content":"Immutep Ltd has released a press release. View Attachment","length":217,"tagName":"div"}]